The stock market is experiencing turbulence on Thursday, October 31, 2024, as investors digest a flurry of earnings reports from tech giants and anticipate crucial economic data. Major indexes are showing signs of weakness...
Stocks fell sharply on Wednesday, with all three major indexes finishing the day near session lows, as some disappointing economic data weighed down investors’ sentiment. The Dow Jones ended the day 0.94% lower at...
NYSE: MRK) reported quarterly earnings results that edged past Street’s estimate, investors were disappointed after the pharmaceutical company provided cautious guidance and said that it would postpone seeking approval for its potential blockbuster osteoporosis...
Pharmaceutical company, Merck & Co Inc. (NYSE: MRK) ended marginally lower on Friday even as it announced better than expected fiscal third-quarter earnings; nevertheless, revenue fell short of Street’s expectations as sales suffered owing...
We have found the following stocks to be trending up over the past 4 days as of Wednesday, October 17, 2012. Definitely worth keeping an eye on. Microsoft Corp. (NASDAQ:MSFT) increased its share price...
List of stocks who have just hit new 52-week highs as of Tuesday, October 16, 2012. Pfizer (NYSE:PFE) hit a new 52 week high of $25.93 in intraday trading and closed at $25.80 +2.71%...
List of stocks who have just hit new 52-week highs as of Monday, October 15, 2012. Pfizer (NYSE:PFE) hit a new 52 week high of $25.62 in intraday trading and closed at $25.57 +1.79%...
Merck KGaA, the German based drug manufacturer has threatened Facebook Inc. with legal actions after it lost its page on the social networking website to rival Merck & Co. (NYSE:MRK) in U.S. According to...
Merck & Co. (NYSE: MRK), the Whitehouse Station, New Jersey-based global health care company, has pleased guilty to a criminal misdemeanor charge that it illegally promoted Vioxx and misled the government about the drug’s...
Merck & Co (NYSE:MRK) made an 11 percent rise in its quarterly dividend for the first time in seven years since Vioxx, Merck’s painkiller, was withdrawn in 2004. The second largest drug maker in...